Despite an increased postremission toxic mortality ( @ years : @ % v. @ % ; HzR , @ ; @ % CI , @ to @ ; P = @ ) , disease-free survival was better among GO recipients ( @ years : @ % v. @ % ; HzR , @ ; @ % CI , @ to @ ; P = @ ) .